Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing

被引:5
作者
De Rosa, Anna [1 ]
Tessitore, Alessandro [2 ]
Silo, Leonilda [1 ]
Peluso, Silvio [1 ]
De Michele, Giuseppe [1 ]
机构
[1] Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Via Pansini 5, I-80131 Naples, Italy
[2] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy
关键词
Parkinson's Disease; Advanced treatment; Nursing; Deep brain stimulation; DUODENAL LEVODOPA INFUSION; BILATERAL SUBTHALAMIC STIMULATION; APOMORPHINE INFUSION; COGNITIVE FUNCTION; NUCLEUS; THERAPIES; LEVODOPA/CARBIDOPA; COMPLICATIONS; FORMULATIONS; SELECTION;
D O I
10.1016/j.gerinurse.2016.06.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Parkinson's Disease (PD) represents one of the most common neurodegenerative disorders in the elderly. PD is caused by a loss of dopaminergic cells in the substantia nigra pars compacta. The motor cardinal signs include a resting tremor, bradykinesia, rigidity and postural reflex impairment. Although levodopa represents the gold standard also in the advanced stage of the disease, over the years most patients develop disabling motor fluctuations, dyskinesias, and non-motor complications, which are difficult to manage. At this stage, more complex treatment approaches, such as infusion therapies (subcutaneous apomorphine and intraduodenal levodopa) and deep brain stimulation of the subthalamic nucleus or the globus pallidus internus should be considered. All three procedures require careful selection and good compliance of candidate patients. In particular, infusional therapies need adequate training both of caregivers and nursing staff in order to assist clinicians in the management of patients in the complicated stages of disease. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:434 / 439
页数:6
相关论文
共 53 条
[1]  
Abbruzzese G, 2012, FUNCT NEUROL, V27, P147
[2]   Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease [J].
Alegret, M ;
Valldeoriola, F ;
Martí, MJ ;
Pilleri, M ;
Junqué, C ;
Rumià, J ;
Tolosa, E .
MOVEMENT DISORDERS, 2004, 19 (12) :1463-1469
[3]   Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease [J].
Alegret, M ;
Junqué, C ;
Valldeoriola, F ;
Vendrell, P ;
Pilleri, M ;
Rumià, J ;
Tolosa, E .
ARCHIVES OF NEUROLOGY, 2001, 58 (08) :1223-1227
[4]   Duodenal levoclopa infusion improves quality of life in advanced Parkinson's disease [J].
Antonini, A. ;
Mancini, F. ;
Canesi, M. ;
Zangaglia, R. ;
Isaias, I. U. ;
Manfredi, L. ;
Pacchetti, C. ;
Zibetti, M. ;
Natuzzi, F. ;
Lopiano, L. ;
Nappi, G. ;
Pezzoli, G. .
NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) :244-246
[5]   Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome [J].
Antonini, Angelo ;
Isaias, Ioannis U. ;
Canesi, Margherita ;
Zibetti, Maurizio ;
Mancini, Francesca ;
Manfredi, Luigi ;
Dal Fante, Marco ;
Lopiano, Leonardo ;
Pezzoli, Gianni .
MOVEMENT DISORDERS, 2007, 22 (08) :1145-1149
[6]   Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson's Disease [J].
Antonini, Angelo .
JOURNAL OF MOVEMENT DISORDERS, 2009, 2 (01) :4-9
[7]   Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management [J].
Antonini, Angelo ;
Tolosa, Eduardo .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (06) :859-867
[8]   Clinical Spectrum of Levodopa-Induced Complications [J].
Aquino, Camila Catherine ;
Fox, Susan H. .
MOVEMENT DISORDERS, 2015, 30 (01) :80-89
[9]  
BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344
[10]   Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease [J].
Benabid, Alim Louis ;
Chabardes, Stephan ;
Mitrofanis, John ;
Pollak, Pierre .
LANCET NEUROLOGY, 2009, 8 (01) :67-81